CASI   $6.75  0.0 Market Closed

CASI Pharmaceuticals Inc
Total Cash 12.73M
totalCashPerShare 0.941
EBITDA -23.08M
Total Debt 18.46M
quickRatio 2.136
currentRatio 3.881
Total Revenue 23.10M
debtToEquity 204.689
Revenue/Share 1.722
ROA -0.26598
ROE -0.85426
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth -0.595
grossMargins 0.56805
ebitdaMargins -0.99911004
operatingMargins -2.40111
profitMargins -1.1767501
enterpriseValue 102.67M
forwardPE -3.366197
floatShares 6.22M
sharesOutstanding 15.46M
sharesShort 166.59K
sharesShortPriorMonth 202.62K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.46%
heldPercentInstitutions 0.24%
Short Ratio help_outline 6.03%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.667
Price To Book help_outline 10.75
earningsQuarterlyGrowth
netIncomeToCommon -27.20M
trailingEps -2.03%
forwardEps -2.13%
enterpriseToEbitda -4.45
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.62 3Q 2024
institutionsCount 27
lastUpdated Sept. 16, 2024, 11:58 a.m.